SEC Filing Details

Document Details

Form
Filing Date
Aug 17, 2022
Document Date
Aug 17, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Turning Point Therapeutics, Inc.
Issuer
Turning Point Therapeutics, Inc.
Filer
Countouriotis Athena

Turning Point Therapeutics is now a
Bristol Myers Squibb company

Select OK for information about Turning Point Therapeutics.

Select BMS to learn more about Bristol Myers Squibb